Biotech

All Articles

ALX's waning CD47 feedback cost sends sell spiraling down

.ALX Oncology's stage 2 gastric cancer cells reaction cost has weakened. After observing its own CD4...

Ionis centers eye ailment from intendeds of Roche-partnered prospect after records disappoint

.One More of Ionis Pharmaceuticals' essential midphase readouts has fallen short of requirements, tr...

Biogen's chief executive officer stated no unsafe deals in 2023. He's ready to become vibrant

.While Biogen's pharma peers are actually hunting for late-stage properties with little risk, chief ...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Biography has been a biotech looking for a pipe after it ditched its own lead properties ove...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back civil liberties to a very early Alzheimer's ailment plan to Denali Rehabs, g...

Takeda taps new head of US oncology company-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings and ...

Vertex, hammered by AATD once more, goes down 2 resources on discard pile

.Tip's try to address a rare hereditary disease has struck another trouble. The biotech shook pair o...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter profits file wasn't except large updates. The firm invited a tri...

Galapagos stops CAR-T cell therapy trial over Parkinsonism instance

.Galapagos has actually stopped briefly enrollment in a trial of a BCMA-directed CAR-T cell treatmen...

James Wilson leaving behind Penn to introduce pair of new biotechs

.After much more than three decades, genetics treatment trailblazer James Wilson M.D., Ph.D., is act...